PathologyWatch, a Salt Lake City, UT-based provider of digital dermatopathology solutions, raised $5M in series A funding.
The round was led by SpringTide Investments and Rock Creek Capital with participation from individual investors.
The company intends to use the funds to triple its sales force, expand marketing efforts, implement a channel partner strategy and develop technology and supervised artificial intelligence (AI) for various cancer lines.
Led by co-founder and CEO Dan Lambert, PathologyWatch provides of digital dermatopathology solutions that can speed the diagnostic process while reducing costs to clinics and enhancing patient care. It offers fully interfaced EMR (Electronic Medical Records) reporting and 24/7 access to digital slides.
Through two programs, ValueWatch and BusinessWatch, dermatology clinics and hospitals can improve operational efficiency by speeding up workflow and improve patient outcomes by utilizing the PathologyWatch expert professional team and partner laboratory services.